title: Payer management of oncology gets serious.
authors.forename: Michael
authors.initials: M
authors.lastname: Snyder
authors.forename: Lee
authors.initials: L
authors.lastname: Goldberg
authors.forename: Tracey
authors.initials: T
authors.lastname: Ryan
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use; D017047:Cost Sharing; D004345:Drug Industry / Q000191:economics* / Q000458:organization & administration; D005260:Female; D018166:Health Care Reform / Q000191:economics; D006801:Humans; D007349:Insurance, Health, Reimbursement / Q000191:economics*; D008297:Male; D008329:Managed Care Programs / Q000191:economics*; D008495:Medical Oncology / Q000191:economics; D020380:Needs Assessment; D009369:Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000191:economics; D018855:Single-Payer System / Q000458:organization & administration*; D014481:United States
chemical_list: D000970:Antineoplastic Agents